Author: Biotech Metropolitan Women

Prostate cancer is the second most common form of cancer affecting men in the United States – 1 in 8 men will be diagnosed with prostate cancer in their lifetimes. The American Cancer Society estimates that in 2022, almost 268,490 new cases of prostate cancer will be detected, and more than 34,500 men will die of the disease. Approximately 3.1 million men in the United States currently identify as prostate cancer survivors. The disease develops more often in both African American men and in Caribbean men of African ancestry than in men of other races. Furthermore, prostate cancer is the second leading cause of cancer death…

Digital biotech company OccamzRazor recently raised $6.1MM in a series A funding round that closed in March 2022. The round was led by Jeff Dean, the head of Google AI, a division of Google dedicated to tackling healthcare problems and advancing scientific discovery by leveraging computer science. OccamzRazor is a biotech startup on a mission to cure brain aging through digital science. The company uses natural language processing, graph prediction, and graph machine learning to map out disease processes related to aging, such as Parkinson’s Disease. The company claims that human capacity is not sufficient to translate all the public…

According to the American Academy of Dermatology Association, one in five Americans will develop skin cancer in their lifetime. Skin cancer is one of the most common cancers that can affect anyone with any skin color. Risk to skin cancer comes from exposure to natural and artificial ultraviolet light, unprotected skin and experiencing sunburns. Mortality rates from skin cancer are largely from melanoma. 20 Americans die every day from melanoma. Mortality rates vary among females, males, and age groups. Research shows men with melanoma have lower survival rates than women in the same age group. The five-year survival rate for…

At a time when most companies are challenged with planning their initial diversity and inclusion dialogues, The Biotechnology Innovation Organization (BIO) had already introduced their first black, woman CEO. She is the third chief executive of the organization that made their announcement on May 14, 2020 and Dr. Michelle McMurry-Heath assumed this role as President and CEO on Jun1, 2020. Dr. McMurry-Heath succeeds Congressmen Jim Greenwood who stepped down in October rounding out his 14-year tenure leading the organization and lobbying to Congress to protect drug developers and promote innovation. BIO is the world’s largest science and public advocacy organization,…

[contact-form-7 id=”63602″ title=”Contact Us”]

When a field that depends on scientific benchwork suddenly moves online, what happens to collaborations and the innovation supply chain? We are seeing the answer to this question play out in real time during the Covid-19 crisis. Across the United States and abroad, measures to safeguard against this serious […] Click here to view original web page at endpts.com

[perfect_survey id=”63559″]

Scientists and artists uniquely strive to conceptualize the impalpable world both around and within us. To understand the interplay of data and emotions that compose our entire existence, one would have to respect, equally, the natural and social sciences. Nurtured by the complexities of nature, is a delicate arrangement of mind, body and soul and for these gifted professionals, the process of discovery in these realms is an infinite challenge. Profound is their passion and is, as history proves, essential to the advancement of civilization. Science and art do not have to be mutually exclusive. Quite arguably, they are equivalent…

FILE – This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2. Also known as 2019-nCoV, the virus causes COVID-19. The sample was isolated from a patient in the U.S. On Tuesday, April 21, 2020, U.S. health […] Click here to view original web page at www.wivb.com

Biotech investors might have had an exciting year in 2019 with an impressive amount of new drug approvals. There were 14 notable bankruptcies last year as well, the highest since 2011. Although it’s less common to see a company declare bankruptcy in the biotech sector than in other industries, […] Click here to view original web page at newyork.citybizlist.com